Compound ID | 765
Class: Pleuromutilin, Quinolone
| Agent Type: | Synthetic; Small molecule; Direct acting; |
| Spectrum of activity: | Gram-positive |
| Mechanism of action: | Protein synthesis inhibitor. Additionally a DNA synthesis inhibitor; bacterial topoisomerase inhibitor; topoisomerase II inhibitor |
| Target Pathogen: | Active against methicillin-resistant Staphylococcus aureus |
| Description: | A mutilin-quinolone hybrid antibiotic |
| Institute where first reported: | Kyorin Pharamaceutical Co., Ltd., Japan |
| Year first mentioned: | 2008 |
| Development status: | Experimental |